Guest Writer

Cleary Gottlieb Steen & Hamilton on evolution and growth in the GP stakes market

A growing set of trends reflects both operational innovation and growing investor interest in the GP stakes market, say Ken Blazejewski, co-leader of the Sponsor Solutions Group, and Florence Zhang, partner, at Cleary Gottlieb Steen & Hamilton.

Travers Smith on key considerations for GPs selling themselves

Structural readiness, team alignment and investor engagement are among the main factors GPs and buyers consider in GP stakes deals, say Victoria Bramall and Alex Dixon, partners at Travers Smith.

Royalty finance comes of age

In a rebounding biotech market, royalty finance can play a far more strategic role, provided it’s executed with disciplined underwriting, smart structuring and a genuine partnership with innovators, according to Ryan Murr, a partner at Gibson, Dunn & Crutcher.

RX Benefits: Proactive pharmacy benefits boost profits

Spiraling pharmacy costs are creating a value creation opportunity for PE firms that are able to curb spending, says RX Benefits business development executive Will Statham.

The new AI value equation for private equity

Companies that succeed are not those seeking to replace humans with machines, but those combining human intelligence with AI to create a multiplier effect, writes Tim Huber of Maine Pointe.

Venture debt: Exploring funding structures

In part 24 of his venture debt series, Zack Ellison of Applied Real Intelligence breaks down the key funding structures behind venture loans and growth credit and how they shape investor control and economics.

Mid-market managers don’t have to miss the retirement capital boat

There is an often-overlooked $17trn market where the mid-market and smaller managers can compete within their own weight class for retirement capital, writes Eric Satz, founder and CEO of self-directed IRA platform Alto.

Essential services are having a moment – and investors are paying attention

Oft overlooked things like HVAC, plumbing, pest control and landscaping add up to a $650bn market with consistent annual growth, write Keith Campbell and Josh Portz of West Monroe.

The GP-led herd is missing the real opportunity

The market’s overreliance on single-asset deals has boxed out many of the situations that need liquidity most, writes Chris Lawrence of Labyrinth Capital Partners.

North America M&A outlook: year starts with dampened expectations

The long-anticipated recovery is only deferred, not called off, writes Daniel Friedman, Global Leader of BCG’s Transactions & Integrations practice.